WideMed sleep monitor granted CE Mark
WideMed will expand its collaboration with GE Healthcare, which will market the Morpheus Hx software in Europe.
WideMed cites a study by Frost and Sullivan, which estimates the European sleep industry market at $10 billion, and that 20 million Europeans suffer from chronic sleep disorders.
The Morpheus Hx includes software based on algorithms that can monitor sleep derived from data from standard sleep monitors manufactured by GE Healthcare. GE Healthcare has over $17 billion in annual turnover. The Morpheus Ox system uses a signal oxymeter to analyze sleep measures.
WideMed expects to launch sales of the Morpheus Ox in Europe in early 2011, provided that the company's suppliers meet delivery schedules.
WideMed's investors include Guidant Corporation, Platinum Neurone Ventures and Ascend Technology Ventures LP. The company's share price rose 16.2% by mid-afternoon to NIS 1.07, giving a market cap of NIS 17 million.
Published by Globes [online], Israel business news - www.globes-online.com - on September 7, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010
- Tel Aviv market report
- Tel Aviv Stock Exchange
- Israeli stocks in NY
- Arbitrage gaps for dual-listed stocks
- Israeli stocks in Europe
- Israeli stocks on other markets
- Tel Aviv 25 options
- Mutual funds
- Current representative shekel rates
- Historical representative shekel rates
- Bank shekel rates
- Shekel/dollar options